Viewing StudyNCT00741377



Ignite Creation Date: 2024-05-05 @ 7:48 PM
Last Modification Date: 2024-10-26 @ 9:54 AM
Study NCT ID: NCT00741377
Status: COMPLETED
Last Update Posted: 2013-02-18
First Post: 2008-08-22

Brief Title: A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma Bone Disease
Keywords:
Name View
antibody View
Multiple myeloma View
bone disease View